[go: up one dir, main page]

ID18095A - Turunan tetrahidrokinolin - Google Patents

Turunan tetrahidrokinolin

Info

Publication number
ID18095A
ID18095A IDP972834A ID972834A ID18095A ID 18095 A ID18095 A ID 18095A ID P972834 A IDP972834 A ID P972834A ID 972834 A ID972834 A ID 972834A ID 18095 A ID18095 A ID 18095A
Authority
ID
Indonesia
Prior art keywords
tetrahidrokinolin
tetrahidrokinolin down
Prior art date
Application number
IDP972834A
Other languages
English (en)
Indonesian (id)
Inventor
Romano Di-Fabio
Alessandra Pasquarello
Fabio Maria Sabbatini
Original Assignee
Glaxo Wellcome Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Spa filed Critical Glaxo Wellcome Spa
Publication of ID18095A publication Critical patent/ID18095A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IDP972834A 1996-08-17 1997-08-14 Turunan tetrahidrokinolin ID18095A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9617305.9A GB9617305D0 (en) 1996-08-17 1996-08-17 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
ID18095A true ID18095A (id) 1998-02-26

Family

ID=10798623

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP972834A ID18095A (id) 1996-08-17 1997-08-14 Turunan tetrahidrokinolin

Country Status (34)

Country Link
US (1) US6479488B1 (fr)
EP (1) EP0922034B1 (fr)
JP (1) JP4108129B2 (fr)
KR (1) KR100552864B1 (fr)
CN (1) CN1131214C (fr)
AP (1) AP877A (fr)
AR (1) AR008296A1 (fr)
AT (1) ATE221052T1 (fr)
AU (1) AU724473B2 (fr)
BR (1) BR9711311B1 (fr)
CA (1) CA2264118C (fr)
CO (1) CO4900066A1 (fr)
CZ (1) CZ296250B6 (fr)
DE (1) DE69714265T2 (fr)
DK (1) DK0922034T3 (fr)
EA (1) EA001704B1 (fr)
ES (1) ES2181030T3 (fr)
GB (1) GB9617305D0 (fr)
HU (1) HU225797B1 (fr)
ID (1) ID18095A (fr)
IL (1) IL128141A0 (fr)
IS (1) IS4953A (fr)
MY (1) MY116952A (fr)
NO (1) NO312241B1 (fr)
NZ (1) NZ333812A (fr)
PE (1) PE107098A1 (fr)
PL (1) PL194532B1 (fr)
PT (1) PT922034E (fr)
SI (1) SI0922034T1 (fr)
TR (1) TR199900336T2 (fr)
TW (1) TW449582B (fr)
WO (1) WO1998007704A1 (fr)
YU (1) YU6799A (fr)
ZA (1) ZA977326B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9706294D0 (en) * 1997-03-26 1997-05-14 Glaxo Wellcome Spa Heterocyclic compound
MY125037A (en) * 1998-06-10 2006-07-31 Glaxo Wellcome Spa 1,2,3,4 tetrahydroquinoline derivatives
US6455734B1 (en) 2000-08-09 2002-09-24 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
GB9929037D0 (en) 1999-12-08 2000-02-02 Glaxo Wellcome Spa Heterocyclic derivatives
DE10132725A1 (de) 2001-07-05 2006-08-03 Grünenthal GmbH Substituierte γ-Lactonverbindungen
IL162616A0 (en) * 2001-12-28 2005-11-20 Acadia Pharm Inc Tetrahydroquinoline analogues as muscarinic agonists
US20050250767A1 (en) * 2003-01-23 2005-11-10 Weiner David M Use of N-desmethylclozapine to treat human neuropsychiatric disease
US20050085463A1 (en) * 2003-01-23 2005-04-21 Weiner David M. Use of N-desmethylclozapine to treat human neuropsychiatric disease
NZ541014A (en) * 2003-01-23 2008-05-30 Acadia Pharm Inc Use of N-desmethylclozapine to treat schizophrenia while increasing the level of activity of a muscarinic receptor
WO2004073639A2 (fr) * 2003-02-19 2004-09-02 Merck & Co. Inc. Traitement de la psychose avec un activateur ectopique du recepteur m1 muscarinique
MXPA06007244A (es) * 2003-12-22 2006-08-18 Acadia Pharm Inc Analogos amino sustituidos de diaril[a,d]ciclohepteno como agonistas muscarinicos y metodos de tratamiento de trastornos neuropsiquiatricos.
RU2006138497A (ru) * 2004-04-01 2008-05-10 Акадиа Фармасьютикалз Инк. (Us) Кристаллические формы n-десметилклозапина
EP1908753B1 (fr) 2005-07-22 2014-12-17 Mochida Pharmaceutical Co., Ltd. Nouveau dérivé d'acétamide d'hétérocyclidène
RU2451014C2 (ru) * 2005-07-22 2012-05-20 Мотида Фармасьютикал Ко., Лтд. Новое производное гетероциклиден ацетамида
US8480797B2 (en) 2005-09-12 2013-07-09 Abela Pharmaceuticals, Inc. Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
EP2324838A1 (fr) * 2005-09-12 2011-05-25 Abela Pharmaceuticals, Inc. Compositions comprenant du diméthylsulfoxyde
US8435224B2 (en) 2005-09-12 2013-05-07 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (DMSO) and related compounds
US7955418B2 (en) 2005-09-12 2011-06-07 Abela Pharmaceuticals, Inc. Systems for removing dimethyl sulfoxide (DMSO) or related compounds or odors associated with same
US20070105836A1 (en) * 2005-10-31 2007-05-10 Lars Pettersson Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders
BRPI0921494A2 (pt) 2008-11-03 2018-10-30 Prad Reasearch And Development Ltd método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
KR20120093993A (ko) 2009-10-30 2012-08-23 아벨라 파마슈티칼스, 인코포레이티드 퇴행성 관절염 치료를 위한 디메틸설폭사이드 및 메틸설포닐메탄 제제
CA2850707C (fr) 2011-10-03 2023-03-21 The University Of Utah Research Foundation Application d'antagonistes du recepteur 5-ht6 dans l'attenuation des deficits cognitifs lies au syndrome de down

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0386839B1 (fr) * 1989-03-08 1997-01-15 Merck Sharp & Dohme Ltd. Dérivés de tétrahydroquinoléine utiles pour les affections neurodégénératives
BR9610733A (pt) 1995-09-29 1999-07-13 Glaxo Wellcome Spa Composto processos para a preparação do mesmo e para o tratamento de um mamífero composição farmacêutica e utilização de um composto

Also Published As

Publication number Publication date
PT922034E (pt) 2002-12-31
NZ333812A (en) 2000-07-28
CA2264118A1 (fr) 1998-02-26
GB9617305D0 (en) 1996-09-25
PE107098A1 (es) 1999-01-15
EP0922034A1 (fr) 1999-06-16
TR199900336T2 (xx) 1999-04-21
IS4953A (is) 1999-01-22
EA199900121A1 (ru) 1999-10-28
DE69714265T2 (de) 2003-03-06
JP2001508031A (ja) 2001-06-19
PL331562A1 (en) 1999-07-19
EP0922034B1 (fr) 2002-07-24
AR008296A1 (es) 1999-12-29
HU225797B1 (en) 2007-09-28
CN1131214C (zh) 2003-12-17
DE69714265D1 (de) 2002-08-29
CA2264118C (fr) 2008-06-17
ES2181030T3 (es) 2003-02-16
HUP9903108A3 (en) 2004-04-28
ZA977326B (en) 1999-02-15
BR9711311B1 (pt) 2009-01-13
CN1227544A (zh) 1999-09-01
WO1998007704A1 (fr) 1998-02-26
BR9711311A (pt) 1999-08-17
SI0922034T1 (en) 2003-02-28
NO990723D0 (no) 1999-02-16
AU4551897A (en) 1998-03-06
KR100552864B1 (ko) 2006-02-20
ATE221052T1 (de) 2002-08-15
MY116952A (en) 2004-04-30
IL128141A0 (en) 1999-11-30
CO4900066A1 (es) 2000-03-27
AP9901459A0 (en) 1999-03-31
NO990723L (no) 1999-04-14
CZ296250B6 (cs) 2006-02-15
PL194532B1 (pl) 2007-06-29
NO312241B1 (no) 2002-04-15
KR20000068172A (ko) 2000-11-25
AP877A (en) 2000-09-27
US6479488B1 (en) 2002-11-12
JP4108129B2 (ja) 2008-06-25
AU724473B2 (en) 2000-09-21
TW449582B (en) 2001-08-11
CZ52999A3 (cs) 1999-07-14
DK0922034T3 (da) 2002-11-18
EA001704B1 (ru) 2001-06-25
YU6799A (sh) 2000-03-21

Similar Documents

Publication Publication Date Title
BR9703884A (pt) Cicloalcanopiridinas
ATE208395T1 (de) Thiophenopyrimidine
BR9704464A (pt) Evisceradora
ATE262512T1 (de) Arylalkanoylpyridazine
ID19474A (id) Turunan tiazola
ATE208773T1 (de) Chinoxalindione
ID18095A (id) Turunan tetrahidrokinolin
ATE353652T1 (de) Östroprogestatives antikonzeptionsmittel
DE59609702D1 (de) Pulversprüheinrichtung
BR9703563A (pt) Hidromancal
BR9703835A (pt) Hidromancal
BR9707467A (pt) 1-Pirazol-3-iletil-4-indol-3-ilpiperdinas
BR9708716A (pt) 3-cianoaril-pirazóis
DE69711532D1 (de) Lithiumborosilikatphosphor
ATE267568T1 (de) Epithese
BR7601419U (pt) Mourao
BR9605291A (pt) Hidro-coleta
BR7601548U (pt) Tomadamax
BR7601508U (pt) Cogafa
BR7601720U (pt) Paraglayder
BR7601926U (pt) Sofá-mesa
FI960237A0 (fi) Injektions- och taetningsmassa
FI965084A0 (fi) Foerfarande foer dataoeverfoering
BR7601310U (pt) Microlivro
BR9606252A (pt) Cromosauna